Oxazepam on Lux 5µm Cellulose-3 by SFC
LC Conditions
Column
Lux 5 µm Cellulose-3, LC Column 250 x 4.6 mm, Ea
Brand
Lux
Part No
00G-4493-E0
Phase Name
Cellulose-3
Elution Type
Isocratic
Mobile Phase
A: CO2/(Methanol + 0.5% IPA) 90:10 (v/v)
Gradient Profile
Step No.
Time(min)
%A
%B
1
0
100
0
Flow Rate
3.00 mL/min
Temperature
30°C
Detection
UV-Vis Abs.-Diode Array (PDA) @ (30°C)
Detection Info
Sample Notes
Courtesy of Katrijn De Klerck, Debby Mangelings and Yvan Vander Heyden, Department of Analytical Chemistry and Pharmaceutical Technology, Vrije Universiteit Brussel, Brussels, Belgium. Results of this analysis yielded: Alpha >1.1 and Resolution >1.5 SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, Lux Cellulose-3, 4 x 3.0mm ID, 10/Pk Part No.: AJ0-8622 - Holder Part No.: KJ0-4282
Order Items Used in This Application
- 1. Oxazepam
- 2. Oxazepam
-OEChem-06211003152D<br><br> 31 33 0 1 0 0 0 0 0999 V2000<br> 8.1647 -0.1360 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3100 -1.1602 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1204 -2.8430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.7188 -2.2836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7439 -0.2592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.5006 -0.6602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.7188 -0.0367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.5006 -1.6602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.9413 0.9383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.3100 -1.1602 0.0000 C 0 0 3 0 0 0 0 0 0 0 0 0<br> 6.3946 -0.1255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3946 -2.1948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7439 -2.0611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.3006 -0.6393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.3006 -1.6810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.8969 1.2330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2083 1.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.1194 2.2079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.4308 2.5934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.3864 2.8881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.9801 -0.6352 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.8568 -2.8881 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3874 0.4945 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3874 -2.8148 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.8364 -1.9930 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3514 0.8113 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.6158 1.4357 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.7119 2.3907 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.9763 3.0151 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.5243 3.4926 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 -0.6232 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 14 1 0 0 0 0<br> 2 10 1 0 0 0 0<br> 2 31 1 0 0 0 0<br> 3 13 2 0 0 0 0<br> 4 8 1 0 0 0 0<br> 4 13 1 0 0 0 0<br> 4 22 1 0 0 0 0<br> 5 7 2 0 0 0 0<br> 5 10 1 0 0 0 0<br> 6 7 1 0 0 0 0<br> 6 8 2 0 0 0 0<br> 6 11 1 0 0 0 0<br> 7 9 1 0 0 0 0<br> 8 12 1 0 0 0 0<br> 9 16 2 0 0 0 0<br> 9 17 1 0 0 0 0<br> 10 13 1 0 0 0 0<br> 10 21 1 0 0 0 0<br> 11 14 2 0 0 0 0<br> 11 23 1 0 0 0 0<br> 12 15 2 0 0 0 0<br> 12 24 1 0 0 0 0<br> 14 15 1 0 0 0 0<br> 15 25 1 0 0 0 0<br> 16 18 1 0 0 0 0<br> 16 26 1 0 0 0 0<br> 17 19 2 0 0 0 0<br> 17 27 1 0 0 0 0<br> 18 20 2 0 0 0 0<br> 18 28 1 0 0 0 0<br> 19 20 1 0 0 0 0<br> 19 29 1 0 0 0 0<br> 20 30 1 0 0 0 0<br>M END
Compound Name
Oxazepam
CID
4616
Molecular Formula
C15H11ClN2O2
Molecular Weight
286
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
2
Similar Applications
Reversed Phase
Drugs of Abuse by LCMS using Kinetex 1.7u Biphenyl 50x2.1mm
Kinetex 1.7 µm Biphenyl 100 Å, LC Column 50 x 2.1 mm, Ea
23445
Reversed Phase
Drugs of Abuse by LCMS using Kinetex 1.7u EVO C18 50x2.1mm
Kinetex 1.7 µm EVO C18 100 Å, LC Column 50 x 2.1 mm, Ea
23444
Chiral
Oxazepram on Lux 5µm Amylose-1 by SFC
Lux 5 µm Amylose-1, LC Column 250 x 4.6 mm, EA
23341
Chiral
Oxazepam on Lux 5µm Amylose-1 by SFC
Lux 5 µm Amylose-1, LC Column 250 x 4.6 mm, EA
23324
Chiral
Oxazepam on Lux 5µm Amylose-1 by SFC
Lux 5 µm Amylose-1, LC Column 250 x 4.6 mm, EA
23306
Reversed Phase
Full Pain Panel using Kinetex 2.6u Biphenyl 50x2.1mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 2.1 mm, Ea
22122
Reversed Phase
Fast Pain Panel using Kinetex 2.6 u Biphenyl 50x3.0mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22121
Reversed Phase
Full Pain Panel using Kinetex 5um Biphenyl 50x3.0mm
Kinetex 5 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22120
Reversed Phase
Pain Panel Benzodiazapines using Kinetex 2.6u Biphenyl 50x3.0mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22109
Reversed Phase
Full Pain Panel using Kinetex 2.6u Biphenyl 50x3.0mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22104
Chiral
Oxazepam on Lux 5µm Cellulose-3 by SFC
Lux 5 µm Cellulose-3, LC Column 250 x 4.6 mm, Ea
21288
Chiral
Oxazepam on Lux 5µm Cellulose-3 by SFC
Lux 5 µm Cellulose-3, LC Column 250 x 4.6 mm, Ea
21287
Chiral
Oxazepam on Lux 5µm Cellulose-3 by SFC
Lux 5 µm Cellulose-3, LC Column 250 x 4.6 mm, Ea
21286
Chiral
Oxazepam on Lux 5µm Cellulose-3 by SFC
Lux 5 µm Cellulose-3, LC Column 250 x 4.6 mm, Ea
21285
Chiral
Oxazepam on Lux 5µm Cellulose-1 by SFC
Lux 5 µm Cellulose-1, LC Column 250 x 4.6 mm, Ea
21284
Chiral
Oxazepam on Lux 5µm Cellulose-1 by SFC
Lux 5 µm Cellulose-1, LC Column 250 x 4.6 mm, Ea
21283
Chiral
Oxazepam on Lux 5µm Cellulose-1 in PO
Lux 5 µm Cellulose-1, LC Column 250 x 4.6 mm, Ea
20283
Chiral
Oxazepam on Lux 5µm Cellulose-1 in RP
Lux 5 µm Cellulose-1, LC Column 250 x 4.6 mm, Ea
20232
Oxazepam Lux 5 µm Amylose-2 250 x 4.6mm in PO-95%CH3CN
18142
Chiral
Oxazepam on Lux 5 µm Cellulose-1 250 x 4.6mm ID in PO-95%CH3CN
Lux 5 µm Cellulose-1, LC Column 250 x 4.6 mm, Ea
18141
Chiral
Oxazapam on Lux 5µ Cellulose-2 250 x 4.6mm in NP
Lux 5 µm Cellulose-2, LC Column 250 x 4.6 mm, Ea
17671
Chiral
Oxazapam on Lux 5µ Cellulose-1 250 x 4.6mm in NP
Lux 5 µm Cellulose-1, LC Column 250 x 4.6 mm, Ea
17663